Trial intelligence / Profile preview

Stinging Potential of Sunscreen Formulas in Human Eyes

NCT02872194Completed

Sponsor
Bayer
Start
Sep 2014
Primary completion
Sep 2014
Modality
Hydrogel Systems, Transdermal Patches
Countries
1
01

Overview

Randomised, single-blind trial of BAY 987516 in sunburn (3 arms), sponsored by Bayer. Primary endpoints: Subjective discomfort in the eye at 24 hours, Tearing/Lacrimation at 24 hours and 2 more. Started Sep 2014; status: completed.

02

Drugs

BAY 987516
03

Conditions

sunburn

Beyond the preview

Go deeper on NCT02872194.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02872194.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call